FoodLife is an advanced system to predict shelf-life of food in the Ho.Re.Ca. sector, reducing waste and enabling timely donations to nonprofits. This system also reduces costs and CO2 emissions.
The Impact Report 2024 presents the key results from numerous projects, challenges, and monitoring initiatives launched over the past year in the Netherlands.
The OECD report reviews global food loss and waste policies, emphasizing the need for clearer targets, better coordination, and evidence-based strategies to meet SDG Target 12.3.
Environmental Protection Agency of Ireland has released guidance to help breweries reduce food waste while also identifying value in unavoidable waste.
Developed by the Environmental Protection Agency of Ireland, this checklist-based guidance helps businesses track progress and take action to reduce food waste in distilling.
The fund will help British farmers and charities redistribute surplus food, reducing waste and cutting associated costs.
This report details the first year of implementation of Ireland's Food Waste Charter.
Succeeding Philip den Ouden, Gerda Verburg will play a key role in advancing the organization’s goal of reducing food waste by 50% by 2030.
Developed by WWF Beijing and the Chinese Academy of Sciences, this guide offers practical strategies for catering businesses, with a focus on small and medium-sized enterprises.
Developed by the Natural Resource Institute Finland, the Lukeloki app helps food service operators track and reduce food waste.
This report provides an overview of food banks in Sweden, focusing on the food redistribution efforts and key challenges in the sector.
Presentation and recording - EUHPP Live Webinar on European Health Data Space (1/3): Primary Use of health data and Electronic Health Record Systems (18 February 2025)
Report of a Joint One Health country visit to Sweden on antimicrobial resistance
REMINDER - EUHPP Live Webinar: Union prevention, preparedness and response plan (28 February 2025, 10:00 - 11:30 CET)
In December 2024, on the ‘Have your say’ portal, the Commission published information on new legislative initiatives (implementing and delegated acts) in support of Regulations (EU) 2017/745 on medical devices (MDR) and (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) as indicated below.
These initiatives are planned to be adopted during 2025.
In January 2025, the first revision of the European Medical Device Nomenclature (EMDN)was made available after a broad consultation process that included stakeholders from around the world. The 2025 cycle of public consultation has been launched via the EMDN submission platform, open to all interested to provide their input to the annual revision.
In November 2024, the EU hosted a training session on the EMDN. The training materials from this event are available here. Further sessions will take place to ensure that all interested parties can benefit from the work.
In December 2024, national authorities in Member States endorsed a new strategy for the COMBINE programme for clinical trials and medical devices, a cross-sector initiative to streamline combined studies of medicines and medical devices, including diagnostics.
For more, see the Commission’s webpage on Combined studies.
In November 2024, the dashboard of the ‘Study supporting the monitoring of the availability of medical devices on the EU market’ was updated.
For more, see the Commission’s web page on the Study supporting the monitoring of availability of medical devices on the EU market.
In December 2024, the second survey round for economic operators dealing with medical devices and in vitro diagnostic medical devices within the ‘Study supporting the monitoring of availability of medical devices on the EU market’ was launched.
The survey, specifically addressed to medical device (MD) and in vitro diagnostic medical device (IVD) manufacturers, authorised representatives, importers and distributors, is open until 28 February 2025.
For more, see the Commission’s web page on the Study supporting the monitoring of availability of medical devices on the EU market.
In December 2024, the European Commission launched a public consultation with an EUSurvey questionnaireand a call for evidence on the EU legislation on medical devices (Regulation (EU) 2017/745, MDR) and in vitro diagnostic medical devices (Regulation (EU) 2017/746, IVDR), as part of the targeted evaluation of these rules.
The consultation and call for evidence are open until 21 March 2025.
For more, see the Commission’s ‘Have your say’ page on EU rules on medical devices and in vitro diagnostics – targeted evaluation.
